Login to Your Account



Yichang seeks to buck market trend, aims for Hong Kong listing

By Pearl Liu
Staff Writer

Tuesday, December 15, 2015

HONG KONG – Even as Asian markets wobble and investors scrutinize every move, Chinese drugmaker Yichang HEC Changjiang Pharmaceutical Co. Ltd. launched an IPO in Hong Kong Monday looking to raise as much as HK$1.67 billion (US$215 million).

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription